Markets settle lower amid selling in blue-chip stocks
The Hindu
Sensex and Nifty close lower, Sensex at 81,508.46 and Nifty at 24,619, impacted by global trends and selling.
Equity benchmark indices Sensex and Nifty ended lower on Monday (December 9, 2024), dragged down by selling in blue-chip stocks Reliance Industries, Hindustan Unilever, Axis Bank and mixed global trend.
After oscillating between highs and lows during the day, the 30-share BSE benchmark Sensex declined 200.66 points or 0.25% to settle at 81,508.46. During the day, it moved between the high of 81,783.28 and low of 81,411.55.
The NSE Nifty slipped 58.80 points or 0.24% to close at 24,619.
From the 30-share pack, Hindustan Unilever, Tata Motors, Axis Bank, Nestle India, Asian Paints, ITC, Reliance Industries, Mahindra & Mahindra, IndusInd Bank and State Bank of India were among the laggards.
Larsen & Toubro, Tata Steel, JSW Steel, HDFC Bank, Adani Ports, Kotak Mahindra Bank, Bharti Airtel and PowerGrid were among the gainers.
"Markets witnessed a range-bound session and mostly languished in negative territory due to lack of investors' enthusiasm after last week's rally," said Prashanth Tapse, Senior VP (Research), Mehta Equities Ltd.
In Asian markets, Seoul and Shanghai settled lower, while Tokyo and Hong Kong ended in the green.
Presently, the problem facing India’s economy is not the lack of growth; the problem lies in its inequitable distribution across the population, partly induced by food price inflation
Despite economic growth, job creation remains a challenge in India as small businesses add 11 million jobs amid high inflation.
Lokpal calls SEBI chief and complainants for oral hearing on corruption complaints based on Hindenburg Research report.
BPCL approved pre-project activities for a greenfield refinery in Andhra Pradesh, aiming to enhance refining capacity and petrochemicals portfolio.
Consumer Affairs Ministry to release guidelines on pesky calls, aligning with TRAI regulations, to protect consumer interests.
Rupee hits all-time low at 85.20 against USD due to strong greenback, rising crude oil prices, and weak domestic markets.
Viatris faces U.S. FDA import alert for products from Indore plant, exceptions made for certain shortages.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.